Vertex Pharmaceuticals Inc / Ma

Bouvel Investment Partners, LLC VRTX

Report date

9/30/2026

Quarter

2026 Q3

Filed

10/13/2026

Shares

10,902

Value ($000)

5,700

Weight

1.3%

2026 Q3 - 2026 Q3 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q3	10/13/2026	5,700	1.3%	10,902	9/30/2026